Mizuho Securities Reiterates Neutral Rating on Walgreens Boosts Alliance (WBA) Following 1Q Report

Go back to Mizuho Securities Reiterates Neutral Rating on Walgreens Boosts Alliance (WBA) Following 1Q Report

Walgreens Boosts Alliance (WBA) PT Lowered to $57 at RBC Capital

January 9, 2020 6:37 AM EST

RBC Capital analyst Anton Hie lowered the price target on Walgreens Boosts Alliance (NASDAQ: WBA) to $57.00 (from $58.00) while maintaining a Sector Perform rating following results.

... More

Walgreens Boosts Alliance (WBA) PT Lowered to $49 at UBS

January 9, 2020 6:20 AM EST

UBS lowered its price target on Walgreens Boosts Alliance (NASDAQ: WBA) to $49.00 (from $50.00) while maintaining a Sell rating.... More

Walgreens Boosts Alliance (WBA) PT Lowered to $57 at Baird

January 8, 2020 3:36 PM EST

Baird analyst Eric W. Coldwell lowered the price target on Walgreens Boosts Alliance (NASDAQ: WBA) to $57.00 (from $58.00) while maintaining a Neutral rating.

... More

Popular stocks with increasing unusual volume: WBA M PYPL STZ BYND APA NIO BA MCD

January 8, 2020 9:49 AM EST

Popular stocks with increasing unusual volume: WBA M PYPL STZ BYND APA NIO BA MCD

... More

Walgreens Boots Alliance (WBA) Extends Decline, Down 6.4%

January 8, 2020 9:48 AM EST

Walgreens Boots Alliance (NASDAQ: WBA) Extends Decline, Down 6.4%

... More

Pre-Open Stock Movers 01/08: (APLT) (VSTM) (M) Higher; (EXFO) (LTHM) (RADA) Lower (more...)

January 8, 2020 9:23 AM EST

Today's Pre-Open Stock Movers:

Applied Therapeutics Inc. (NASDAQ: APLT) 22.3% HIGHER; announced positive topline results from the Pivotal Phase 2 portion of the ACTION-Galactosemia study of AT-007, a central nervous system (CNS) penetrant Aldose Reductase inhibitor, in adult Galactosemia patients. ACTION-Galactosemia is a double-blind placebo-controlled trial evaluating safety and pharmacokinetics of AT-007 in healthy volunteers, as well as safety, pharmacokinetics, and biomarker effects in adult Galactosemia patients over 28 days of once daily oral dosing. The key biomarker outcome of the study was reduction in galactitol, an aberrant toxic metabolite of galactose,... More

Walgreens misses profit estimates on pharmacy weakness, shares fall 7%

January 8, 2020 7:10 AM EST

By Manas Mishra and Trisha Roy

(Reuters) - Walgreens Boots Alliance Inc's (NASDAQ: WBA) quarterly profit missed Wall Street estimates on Wednesday, hit by lower payments from insurers on drugs sold at its U.S. pharmacies, knocking back its shares and those of rival CVS Health Corp (NYSE: CVS).

The company sought to reassure investors, saying it would meet its adjusted full-year profit forecast of roughly flat growth, betting on cost cuts and a harsh flu season.

But shares fell nearly 7% to $55, dragging down those... More

Walgreens Boots Alliance (WBA) Misses Q1 EPS by 4c

January 8, 2020 7:01 AM EST

Walgreens Boots Alliance (NASDAQ: WBA) reported Q1 EPS of $1.37, $0.04 worse than the analyst estimate of $1.41. Revenue for the quarter came in at $34.3 billion versus the consensus estimate of $34.59 billion.

Fiscal 2020 outlook:

Company maintained its guidance of roughly flat growth in fiscal... More

Options expected to have increasing volume: WBA BBBY LEN

January 8, 2020 4:39 AM EST

Options expected to have increasing volume: WBA BBBY LEN

... More

Wall Street rises but ends well off day's highs amid renewed Middle East jitters

January 8, 2020 12:56 AM EST

By Caroline Valetkevitch

NEW YORK (Reuters) - U.S. stocks ended higher on Wednesday, but the day's uneven path showed investors' sensitivity to any signs of turmoil in the Middle East, with stocks rising on comments by President Donald Trump and paring gains on reports of blasts in Baghdad.

Trump spoke at a White House briefing after Iran's missile strikes overnight on military bases housing U.S. troops in Iraq. The U.S. president said the strikes had not harmed any Americans and that Tehran appeared to be standing down.

Comments earlier from Iran's foreign... More

Walgreens Boots Alliance (WBA) calls active into EPS and outlook

January 7, 2020 11:30 AM EST

Walgreens Boots Alliance (NASDAQ: WBA) January weekly call option implied volatility is at 58, January is at 37, February is at 26; compared to its 52-week range of 19 to 36 into the expected release of quarter results on January 8. Call put ratio 2.6 calls to 1 put with focus on January weekly 60 calls.

... More

Stocks with Implied Volatility Movement

January 7, 2020 4:27 AM EST

Walgreens Boots Alliance (NASDAQ: WBA) volatility index movement increasing vs. 30D HV

... More